Press Releases
Filters
September 16, 2024
Viatris to Report Third Quarter 2024 Financial Results on November 7, 2024
September 10, 2024
Viatris Announces Expiration and Results of Any and All Cash Tender Offers
September 10, 2024
Viatris Announces the Pricing Terms of Pending Any and All Cash Tender Offers
August 23, 2024
Viatris Presents Late Breaking Abstract on Cenerimod at the 26th Asia-Pacific League of Associations for Rheumatology Annual Congress
July 3, 2024
Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture
July 2, 2024
U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation
June 26, 2024
Viatris Statement Regarding European Commission’s Approval for Proposed Divestiture of its Over-the-Counter Business to Cooper Consumer Health
Displaying 11 - 20 of 137